" class="no-js "lang="en-US"> UK Gov Archives - Medtech Alert
Friday, April 12, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

NHS Fast Tracks New ‘Gamechanging’ Drug for Lung Cancer

A targeted new drug for a rare and aggressive form of lung cancer will be […]

Evusheld Approved to Prevent COVID-19 in People Whose Immune Response is Poor

A new medicine, Evusheld (tixagevimab/cilgavimab), has today been authorised for COVID-19 prevention by the Medicines […]

England to Return to Plan A Following the Success of the Booster Programme

The government has today announced that England will fully return to Plan A on Thursday […]

NHS Launches Landmark Mental Health Campaign With ‘Help!’ From The Beatles

Today, the NHS will launch a new landmark campaign using the iconic Beatles song ‘Help!” […]

Government Sets Clear Ambition to Close Gender Health Gap

Decades of gender health inequality will be addressed as the government publishes its vision to […]

UK's Most Vulnerable People to Receive Life-saving COVID-19 Treatments in the Community

Thousands of the UK’s most vulnerable people will be among the first in the world to […]

Government to Invest £375 Million in Neurodegenerative Disease Research

People living with neurodegenerative diseases could live longer, healthier lives due to innovative new research, […]

Lateral Flow Tests to be Introduced for Vaccinated International Arrivals

Eligible fully vaccinated passengers arriving in England from countries not on the red list can […]

Health Secretary has Genome Sequenced for Project Tackling Health Disparities

Health and Social Care Secretary Sajid Javid visited Great Ormond Street Hospital today to provide […]

New Study to Test Third COVID-19 Vaccine for People with Weakened Immune Systems

A new clinical trial to determine whether a third dose of vaccine will improve the […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more